AKT1 and inflammatory bowel disease: SUMOylation of intestinal epithelial cells (IECs) can reduce the severity of inflammatory bowel disease (IBD) by inhibiting the activity of master regulators, including the serine‐threonine kinase AKT1 (Table 8).985